Form 4: Calumet Inc. Director Acquires Shares and Warrants in Corporate Reorganization
SEC Form 4 Filing
Jennifer Straumins, a director of Calumet Inc., acquired 825,000 shares of common stock and 300,000 warrants as part of a corporate reorganization.
Summary
- On July 10, 2024, Calumet Specialty Products Partners, L.P. underwent a corporate reorganization, converting from a master limited partnership to a corporation, Calumet Inc.
- As part of this reorganization, Calumet Merger Sub I LLC merged with Calumet GP, LLC, the general partner of the Partnership.
- Jennifer Straumins, a director of Calumet Inc., received 825,000 shares of Calumet Inc. common stock and 300,000 warrants to purchase common stock.
- The warrants have an exercise price of $20 and expire on July 10, 2027.
- Straumins disclaims beneficial ownership of the shares, except to the extent of any pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing simply reports a transaction related to a corporate reorganization. There's no inherent positive or negative implication.
Industry Context
Form 4 filings are standard practice when company insiders, like directors, buy or sell company stock; this filing reflects changes in Straumins' holdings due to the corporate reorganization.
Key Dates
| Date | Description |
|---|---|
| 07/10/2024 | Date of corporate reorganization, GP Merger, and acquisition of shares and warrants. |
| 07/10/2027 | Expiration date of the warrants. |
| 07/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.